市場調査レポート

商品コード

1632578

動物用調剤の世界市場：市場規模・シェア・動向分析 (製品別・動物の種類別・投与経路別・剤形別・地域別・セグメント別、2025年～2030年)

Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2024年12月31日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 857,157円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,001,217円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,289,337円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

動物用調剤市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の動物用調剤の市場規模は2030年までに24億5,000万米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR 8.29%で成長すると予測されています。市場成長を促進する主な要因としては、ペットの飼育数の増加、膨大な動物医療支出、特殊医薬品に関する飼い主の意識の高まり、ブランド化された動物用医薬品の高コスト、ペットの人間化動向、オーダーメイドの動物用配合薬需要の増加などが挙げられます。

COVID-19パンデミックは、他のいくつかの世界的産業と同様に、2020年の動物用調剤市場にマイナスの影響を与えました。COVID-19が動物用医療システムに及ぼした最も大きな影響は、サプライチェーンの混乱、売上の減少、需要の鈍化、規制と政策の変化によってもたらされた経営課題です。多くの地域が州をあげての封鎖措置に入り、人や物資の移動に制限が課されたため、製造会社、動物用薬局、動物用治療サービス提供者は深刻な影響を受けました。例えば、米国獣医師会によると、2020年4月にはコロナウイルスの発生により約60%の動物病院が診療を中止または延期し、2020年7月には約30%まで減少しました。このように、COVID-19の影響は市場の成長を妨げています。

動物用医薬品の調剤は、動物用治療薬として認可されている医薬品の入手が容易でないことや、他の動物用医薬品の代替品によって残されたギャップを埋めるものです。特定の病状についてFDA認可の医薬品を入手することが困難な場合、配合薬は幅広い動物の疾病を治療するためのより良い選択肢となります。例えば、チュアブル錠は特定の剤形で商業的に承認された製品であり、特定の動物種への使用が推奨されていますが、猫やエキゾチックペットのような動物への使用は受け入れられません。同様に、広く市販されている医薬品は、動物によっては不快な味がするため、投与率が制限されます。このような場合、特に投与が困難な薬剤については、動物用調剤が望ましいです。

パンデミックの間、ペットの飼育はかなり増加し、動物用医療インフラの増加につながり、動物用配合剤市場を牽引しました。2021年5月に米国動物虐待防止協会 (ASPCA) が発表した報告書によると、COVID-19の大流行が始まって以来、5世帯に1世帯が猫や犬を飼うようになりました。パンデミックの間の養子縁組によってもたらされたペットの健康への関心の高まりは、今後数年間の動物用調剤市場の拡大を促進すると予想されます。

同様に、世界の動物用調剤市場は、市場参入企業が獣医の健康に関するプログラムやイニシアチブに注力していることから拡大が見込まれています。例えば、2021年6月、Covetrusは、約1,000の診療所にサービスを提供し、現在、VCPによって有効化されたウェルネスプランを通じて350,000以上のペットに利益をもたらしている獣医ウェルネスプランを管理するためのプラットフォームであるVCPを買収しました。Covetrusは、VCPが提供するインフラと技術プラットフォームを活用し、獣医がペットの飼い主とより緊密な関係を築き、ビジネスと医療の両面でより良い結果を生み出すための新しい方法を提供します。

動物用調剤市場：分析概要

動物の種類別では、ペット向けセグメントが2024年に最大の収益シェアを占めました。これは、ペット動物の採用が増加していること、動物への支出が増加していること、ペット動物用の配合薬の需要が増加していることに起因しています。
製品別では、中枢神経系薬剤セグメントが2024年に約33%の市場シェアを占めました。中枢神経系薬剤は、ペットの行動変化、失明、発作、てんかんなどの神経症状を治療するために最も頻繁に処方される薬剤であるためです。ホルモン剤と代用剤は、動物のホルモンバランスの乱れの治療により適しており、より強力であるため、9.0%以上の割合で急成長している分野です。
投与経路の中では、経口薬が最も好まれ、簡便で受け入れられやすい薬物投与経路であるため、経口薬セグメントは2024年に53%以上の最大市場シェアを占めました。一方、局所薬は投与経路の中で最も急成長しているセグメントであり、予測期間中の成長率は9.0%を超えています。
剤形別では、懸濁液が動物用に最も多く調剤される剤形であることから、懸濁液セグメントは2024年に約49%の最大の売上シェアを占めました。溶液セグメントは、他の固形剤形と比較した溶液のいくつかの利点により、今後数年間で8%以上の最高のCAGRを記録すると推定されます。溶液は通常、固形剤よりも吸収が早く、消化管粘膜に優しいです。さらに、懸濁液とは異なり、溶液では保存中の相分離は問題にならないです。このため、予測期間中は溶液製剤の人気が高まると予想されます。
ペットの飼育数の増加、動物医療費の増加、動物用調剤の需要の高さから、2024年の地域別市場シェアは北米が約40%と最も高いです。アジア太平洋は、ペットのヒューマニゼーションの増加、動物医療支出の増加、低コストの動物用調合薬の入手可能性により、CAGR 約10.0%の最速成長が見込まれています。

市場シェア分析：地域別 (2024年・2030年)
地域市場ダッシュボード
市場規模の予測と動向分析 (2018～2030年)
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ノルウェー
- デンマーク
- スウェーデン
アジア太平洋
- 日本
- 中国
- インド
- 韓国
- オーストラリア
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

市場参入企業の概要
企業の市場ポジション分析
企業分類
戦略マッピング
企業プロファイル/上場企業
- WEDGEWOOD PHARMACY
- Vimian
- Pharmaca
- Akina Animal Health
- Triangle Compounding
- Davis Islands Pharmacy and Compounding Lab
- Custom Med Compounding Pharmacy
- Central Compounding Center South
- Wellness Pharmacy of Cary
- Miller's Pharmacy

第10章重要なポイント

図表

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 4 Global Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 5 Global Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 6 Global Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 7 Global Animal Drug Compounding Market, By Region, 2018 - 2030 (USD Million)
Table 8 North America Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 10 North America Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 11 North America Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 12 North America Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 13 U.S. Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 14 U.S. Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 15 U.S. Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 16 U.S. Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 17 Canada Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 18 Canada Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 19 Canada Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 20 Canada Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 21 Mexico Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 22 Mexico Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 23 Mexico Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 24 Mexico Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 25 Europe Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 26 Europe Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 27 Europe Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 28 Europe Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 29 Europe Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 30 Germany Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 31 Germany Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 32 Germany Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 33 Germany Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 34 UK Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 35 UK Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 36 UK Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 37 UK Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 38 France Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 39 France Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 40 France Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 41 France Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 42 Italy Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 43 Italy Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 44 Italy Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 45 Italy Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 46 Spain Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 47 Spain Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 48 Spain Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 49 Spain Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 50 Denmark Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 51 Denmark Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 52 Denmark Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 53 Denmark Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 54 Sweden Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 55 Sweden Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 56 Sweden Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 57 Sweden Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 58 Norway Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 59 Norway Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 60 Norway Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 61 Norway Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 67 China Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 68 China Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 69 China Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 70 China Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 71 Japan Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 72 Japan Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 73 Japan Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 74 Japan Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 75 India Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 76 India Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 77 India Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 78 India Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 79 South Korea Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 80 South Korea Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 81 South Korea Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 82 South Korea Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 83 Australia Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 84 Australia Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 85 Australia Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 Australia Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 87 Latin America Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 88 Latin America Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 89 Latin America Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 90 Latin America Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Latin America Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 92 Brazil Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 93 Brazil Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 94 Brazil Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 95 Brazil Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 96 Argentina Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 97 Argentina Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 98 Argentina Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 99 Argentina Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 100 Middle East & Africa Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 101 Middle East & Africa Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 102 Middle East & Africa Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 105 South Africa Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 106 South Africa Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 107 South Africa Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 108 South Africa Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 113 UAE Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 114 UAE Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 115 UAE Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 116 UAE Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 117 Kuwait Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 118 Kuwait Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 119 Kuwait Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 120 Kuwait Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Animal Drug Compounding Market, Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter's Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Animal Drug Compounding Market, for Product, 2018 - 2030 (USD Million)
Fig. 15 Global Animal Drug Compounding Market, for Anti-infective Agents, 2018 - 2030 (USD Million)
Fig. 16 Global Animal Drug Compounding Market, for Anti-inflammatory Agents, 2018 - 2030 (USD Million)
Fig. 17 Global Animal Drug Compounding Market, for Hormones & Substitutes, 2018 - 2030 (USD Million)
Fig. 18 Global Animal Drug Compounding Market, for CNS Agents, 2018 - 2030 (USD Million)
Fig. 19 Global Animal Drug Compounding Market, for Other Products, 2018 - 2030 (USD Million)
Fig. 20 Global Animal Drug Compounding Market, for Animal Type, 2018 - 2030 (USD Million)
Fig. 21 Global Animal Drug Compounding Market, for Companion Animal, 2018 - 2030 (USD Million)
Fig. 22 Global Animal Drug Compounding Market, for Dogs, 2018 - 2030 (USD Million)
Fig. 23 Global Animal Drug Compounding Market, for Cats, 2018 - 2030 (USD Million)
Fig. 24 Global Animal Drug Compounding Market, for Others, 2018 - 2030 (USD Million)
Fig. 25 Global Animal Drug Compounding Market, for Livestock Animal, 2018 - 2030 (USD Million)
Fig. 26 Global Animal Drug Compounding Market, for Route of Administration, 2018 - 2030 (USD Million)
Fig. 27 Global Animal Drug Compounding Market, for Oral, 2018 - 2030 (USD Million)
Fig. 28 Global Animal Drug Compounding Market, for Injectable, 2018 - 2030 (USD Million)
Fig. 29 Global Animal Drug Compounding Market, for Topical, 2018 - 2030 (USD Million)
Fig. 30 Global Animal Drug Compounding Market, for Other Routes, 2018 - 2030 (USD Million)
Fig. 31 Global Animal Drug Compounding Market, for Dosage Form, 2018 - 2030 (USD Million)
Fig. 32 Global Animal Drug Compounding Market, for Suspensions, 2018 - 2030 (USD Million)
Fig. 33 Global Animal Drug Compounding Market, for Solutions, 2018 - 2030 (USD Million)
Fig. 34 Global Animal Drug Compounding Market, for Capsules, 2018 - 2030 (USD Million)
Fig. 35 Regional Outlook, 2024 & 2030
Fig. 36 North America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 37 U.S. Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 38 Canada Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 39 Mexico Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 40 Europe Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 41 Germany Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 42 UK Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 43 France Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 44 Italy Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 45 Spain Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 46 Denmark Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 47 Sweden Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 48 Norway Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 50 Japan Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 51 China Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 52 India Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 53 Australia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 54 South Korea Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 55 Latin America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 56 Brazil Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 57 Argentina Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 58 Middle East and Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 59 South Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 61 UAE Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 62 Kuwait Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 63 Company categorization
Fig. 64 Company market position analysis
Fig. 65 Strategic framework

Product Code: GVR-4-68040-040-6

Animal Drug Compounding Market Growth & Trends:

The global animal drug compounding market size is anticipated to reach USD 2.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.29% from 2025 to 2030. The key factors driving the market growth include a rise in pet adoption, huge animal healthcare spending, increased pet owner awareness regarding specialty pharmaceuticals, the high cost of branded veterinary products, pet humanization trends, and an increase in the demand for custom-made, compounded animal medications.

The COVID-19 pandemic had a negative impact on the market for animal drug compounding in 2020, just like on several other global industries. The most significant effects of COVID-19 on the veterinary healthcare system are supply chain disruptions, a drop in sales, a slowdown in demand, and operational challenges brought on by shifting regulations and policies. Manufacturing firms, veterinary pharmacies, and animal care service providers were severely impacted as many areas entered state-wide lockdowns and imposed restrictions on the movement of people and goods. For instance, according to the American veterinary medical association, in April 2020, approximately 60% of veterinary practices were canceled or delayed due to the outbreak of coronavirus and in July 2020, the number of veterinary practices declined to about 30%. Thus, the impact of COVID-19 has hampered market growth.

Compounding veterinary drugs fills the gaps left by less readily available licensed drugs for veterinary treatment and other veterinary medication alternatives. Compounded medications are a better choice for treating a wide range of animal diseases when FDA-approved drugs are difficult to find for certain medical conditions. For instance, chewable tablets are commercially approved products in specific dosage forms and are suggested for use in certain animal species yet are unacceptable for use in animals such as cats or exotic pets. Similarly, widely available medications have an unpleasant taste for some animals limiting the administering rate. In this case, animal drug compounding is preferred, particularly for difficult-to-administer medications.

During the pandemic, pet adoption considerably increased, leading to an increased animal healthcare infrastructure and driving the market for compounded medications for animals. According to a report published by the American Society for the Prevention of Cruelty to Animals (ASPCA) in May 2021, one in every five families had adopted a cat or dog since the COVID-19 pandemic began. The increased focus on pet health brought on by adoptions during the pandemic is expected to drive the expansion of the animal drug compounding market over the coming years.

Similarly, the global animal drug compounding market is expected to expand due to market players focusing on programs and initiatives concerning veterinary health. For instance, in June 2021, Covetrus acquired VCP, a platform for administering veterinary wellness plans that serves about 1,000 practices and presently benefits over 350,000 pets through wellness plans that are enabled by VCP. Covetrus will make use of the infrastructure and technology platform provided by VCP to offer new methods for vets to develop closer bonds with their pet owners and produce better results in terms of both business and healthcare.

Animal Drug Compounding Market Report Highlights:

Based on animal type, the companion animals segment accounted for the largest revenue share in 2024. This can be attributed to the increasing adoption of pet animals, the rise in animal expenditure, and the increasing demand for compounding medication for pet animals.
Based on products, the CNS agents segment dominated with a market share of around 33% in 2024, as CNS agents are the most frequently prescribed medication for treating neurological conditions such as changes in behavior, blindness, seizures, epilepsy, etc., in pets. Hormones & Substitutes is the fastest-growing segment with a rate of over 9.0% since it is better and more potent for hormonal imbalance treatment in animals.
Among routes of administration, the oral segment held the largest market share of more than 53 % in 2024, as oral formulations are the preferred, easy, and more acceptable route of drug administration. Whereas, topical is the fastest-growing segment among the routes of administration, with a growth rate of over 9.0% during the forecast period.
Based on dosage form, the suspensions segment accounted for the largest revenue share of about 49% in 2024, as suspensions were the most dispensed compounded dosage form for animals. The Solutions segment is estimated to register the highest CAGR of over 8% in the coming years owing to the several benefits of the solution compared to another solid dosage form. Solutions are usually more GI mucosa-friendly than solid dosage forms as they are more quickly absorbed. In addition, unlike suspensions, phase separation during storing is not an issue with solutions. Thus, solutions are expected to gain popularity during the forecast period.
North America attributed the largest share of about 40% of the market by region in 2024, owing to an increase in pet ownership together with rising animal health expenditure and high demand for animal drug compounding. While Asia pacific is expected to grow at the fastest CAGR of about 10.0% due to an increase in pet humanization, growing animal healthcare expenditure, and the availability of low-cost animal compounding medications.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Animal Type
- 1.2.3. Route of Administration
- 1.2.4. Dosage Form
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Animal Drug Compounding Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Animal Drug Compounding Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Anti-infective Agents
- 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Anti-inflammatory Agents
- 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Hormones & Substitutes
- 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. CNS Agents
- 4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Other Products
- 4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Animal Drug Compounding Market: Animal Type Business Analysis

5.1. Animal Type Market Share, 2024 & 2030
5.2. Animal Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
5.4. Companion Animal
- 5.4.1. Dogs
  - 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.2. Cats
  - 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.3. Horses
  - 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.4. Others
  - 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Livestock Animal
- 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Animal Drug Compounding Market: Route of Administration Business Analysis

6.1. Route of Administration Market Share, 2024 & 2030
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Oral
- 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Injectable
- 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Topical
- 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Other Routes
- 6.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Animal Drug Compounding Market: Dosage Form Business Analysis

7.1. Dosage Form Market Share, 2024 & 2030
7.2. Dosage Form Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
7.4. Suspensions
- 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Solutions
- 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Capsules
- 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Animal Drug Compounding Market: Regional Estimates & Trend Analysis by Product, Animal Type, Route of Administration, and Dosage Form

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. North America animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. U.S. animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Canada animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Mexico animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Europe
- 8.5.1. Europe animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. UK animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Germany animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. France animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Italy animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Spain animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Norway animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Denmark
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Denmark animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.9. Sweden
  - 8.5.9.1. Key country dynamics
  - 8.5.9.2. Sweden animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Japan animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. China animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. India animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. South Korea animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.6. Australia
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Australia animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Brazil animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Argentina animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.8. MEA
- 8.8.1. MEA animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. South Africa animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Saudi Arabia animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. UAE animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key country dynamics
  - 8.8.5.2. Kuwait animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
- 9.5.1. WEDGEWOOD PHARMACY
  - 9.5.1.1. Overview
  - 9.5.1.2. Financial performance
  - 9.5.1.3. Product benchmarking
  - 9.5.1.4. Strategic initiatives
- 9.5.2. Vimian
  - 9.5.2.1. Overview
  - 9.5.2.2. Financial performance
  - 9.5.2.3. Product benchmarking
  - 9.5.2.4. Strategic initiatives
- 9.5.3. Pharmaca
  - 9.5.3.1. Overview
  - 9.5.3.2. Financial performance
  - 9.5.3.3. Product benchmarking
  - 9.5.3.4. Strategic initiatives
- 9.5.4. Akina Animal Health
  - 9.5.4.1. Overview
  - 9.5.4.2. Financial performance
  - 9.5.4.3. Product benchmarking
  - 9.5.4.4. Strategic initiatives
- 9.5.5. Triangle Compounding
  - 9.5.5.1. Overview
  - 9.5.5.2. Financial performance
  - 9.5.5.3. Product benchmarking
  - 9.5.5.4. Strategic initiatives
- 9.5.6. Davis Islands Pharmacy and Compounding Lab
  - 9.5.6.1. Overview
  - 9.5.6.2. Financial performance
  - 9.5.6.3. Product benchmarking
  - 9.5.6.4. Strategic initiatives
- 9.5.7. Custom Med Compounding Pharmacy
  - 9.5.7.1. Overview
  - 9.5.7.2. Financial performance
  - 9.5.7.3. Product benchmarking
  - 9.5.7.4. Strategic initiatives
- 9.5.8. Central Compounding Center South
  - 9.5.8.1. Overview
  - 9.5.8.2. Financial performance
  - 9.5.8.3. Product benchmarking
  - 9.5.8.4. Strategic initiatives
- 9.5.9. Wellness Pharmacy of Cary
  - 9.5.9.1. Overview
  - 9.5.9.2. Financial performance
  - 9.5.9.3. Product benchmarking
  - 9.5.9.4. Strategic initiatives
- 9.5.10. Miller's Pharmacy
  - 9.5.10.1. Overview
  - 9.5.10.2. Financial performance
  - 9.5.10.3. Product benchmarking
  - 9.5.10.4. Strategic initiatives

動物用調剤の世界市場：市場規模・シェア・動向分析 (製品別・動物の種類別・投与経路別・剤形別・地域別・セグメント別、2025年～2030年)

Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030

動物用調剤市場の成長と動向：

動物用調剤市場：分析概要

目次

第1章分析方法・範囲

第2章エグゼクティブサマリー

第3章動物用調剤市場：変動要因・傾向・範囲

第4章動物用調剤市場：製品別のビジネス分析

第5章動物用調剤市場：動物の種類別のビジネス分析

第6章動物用調剤市場：投与経路別のビジネス分析

第7章動物用調剤市場：剤形別のビジネス分析

第8章動物用調剤市場：地域別の推定と動向分析 (製品別・動物の種類別・投与経路別・剤形別)

第9章競合情勢

第10章重要なポイント

List of Tables

List of Figures

Animal Drug Compounding Market Growth & Trends:

Animal Drug Compounding Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Animal Drug Compounding Market Variables, Trends, & Scope

Chapter 4. Animal Drug Compounding Market: Product Business Analysis

Chapter 5. Animal Drug Compounding Market: Animal Type Business Analysis

Chapter 6. Animal Drug Compounding Market: Route of Administration Business Analysis

Chapter 7. Animal Drug Compounding Market: Dosage Form Business Analysis

Chapter 8. Animal Drug Compounding Market: Regional Estimates & Trend Analysis by Product, Animal Type, Route of Administration, and Dosage Form

Chapter 9. Competitive Landscape

Chapter 10. Key Takeaways

動物用調剤の世界市場：市場規模・シェア・動向分析 (製品別・動物の種類別・投与経路別・剤形別・地域別・セグメント別、2025年～2030年)

Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030

動物用調剤市場の成長と動向：

動物用調剤市場：分析概要

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 動物用調剤市場：変動要因・傾向・範囲

第4章 動物用調剤市場：製品別のビジネス分析

第5章 動物用調剤市場：動物の種類別のビジネス分析

第6章 動物用調剤市場：投与経路別のビジネス分析

第7章 動物用調剤市場：剤形別のビジネス分析

第8章 動物用調剤市場：地域別の推定と動向分析 (製品別・動物の種類別・投与経路別・剤形別)

第9章 競合情勢

第10章 重要なポイント

List of Tables

List of Figures

Animal Drug Compounding Market Growth & Trends:

Animal Drug Compounding Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Animal Drug Compounding Market Variables, Trends, & Scope

Chapter 4. Animal Drug Compounding Market: Product Business Analysis

Chapter 5. Animal Drug Compounding Market: Animal Type Business Analysis

Chapter 6. Animal Drug Compounding Market: Route of Administration Business Analysis

Chapter 7. Animal Drug Compounding Market: Dosage Form Business Analysis

Chapter 8. Animal Drug Compounding Market: Regional Estimates & Trend Analysis by Product, Animal Type, Route of Administration, and Dosage Form

Chapter 9. Competitive Landscape

Chapter 10. Key Takeaways

第1章分析方法・範囲

第2章エグゼクティブサマリー

第3章動物用調剤市場：変動要因・傾向・範囲

第4章動物用調剤市場：製品別のビジネス分析

第5章動物用調剤市場：動物の種類別のビジネス分析

第6章動物用調剤市場：投与経路別のビジネス分析

第7章動物用調剤市場：剤形別のビジネス分析

第8章動物用調剤市場：地域別の推定と動向分析 (製品別・動物の種類別・投与経路別・剤形別)

第9章競合情勢

第10章重要なポイント